Share
When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
Manage episode 515214071 series 3363968
Content provided by Docs Who Lift. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Docs Who Lift or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Show Notes:
In this episode of Docs Who Lift, the Nadolsky brothers welcome back Dr. Sean Wharton, clinical trialist and one of the leading researchers behind the next generation of oral GLP-1 medications. Together, they break down:
The OASIS-4 trial results on 25mg oral semaglutide and how it stacks up to injectable Wegovy
How orforglipron, Eli Lilly’s new small-molecule GLP-1, differs from peptide-based drugs
Why these new therapies could make weight management more accessible and affordable
The fascinating pharmacology behind “snack molecules” and small-molecule receptor agonists
Common misconceptions about bioavailability, dosing, and side effects
The potential role of oral GLP-1s for patients with mild obesity or cardiometabolic disease
Whether you’re a clinician, researcher, or patient curious about the future of obesity medicine, this conversation offers a clear look at how science is shifting toward needle-free solutions.
Oasis 1 Trial Link
Oasis 4 Trial Link
Attain 1 Trial Link
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
135 episodes
))
